EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.4.4.2 | Hyperglycinemia, Nonketotic |
593763 |
Studies of the glycine cleavage enzyme system in brain from infants with glycine encephalopathy. |
ongoing research unassigned |
1 0 |
1.4.4.2 | Carcinoma |
1152352 |
[Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)] |
causal interaction diagnostic usage unassigned |
3 1 0 |
1.4.4.2 | Neoplasms |
1152352 |
[Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)] |
causal interaction diagnostic usage unassigned |
3 1 0 |
1.4.4.2 | Stomach Neoplasms |
1152352 |
[Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)] |
causal interaction diagnostic usage unassigned |
3 1 0 |
1.4.4.2 | Neoplasms |
1333120 |
Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. |
ongoing research therapeutic application unassigned |
1 3 0 |
1.4.4.2 | Hypertension |
1450132 |
The variability of urinary protein and creatinine excretion in patients with gestational proteinuric hypertension. |
diagnostic usage unassigned |
2 0 |
1.4.4.2 | Pharyngitis |
1551976 |
Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. |
diagnostic usage ongoing research therapeutic application unassigned |
3 3 1 0 |
1.4.4.2 | Distemper |
1588321 |
Molecular characterization of phocine distemper virus: gene order and sequence of the gene encoding the attachment (H) protein. |
unassigned |
0 |
1.4.4.2 | Hyperglycinemia, Nonketotic |
1671321 |
The glycine cleavage system: structure of a cDNA encoding human H-protein, and partial characterization of its gene in patients with hyperglycinemias. |
causal interaction ongoing research unassigned |
4 1 0 |
1.4.4.2 | Distemper |
1698923 |
Immunological relationships between phocid and canine distemper virus studied with monoclonal antibodies. |
ongoing research therapeutic application unassigned |
2 2 0 |